Teleflex Incorporated vs Johnson & Johnson
TFX vs JNJ — side-by-side comparison from reported financials. TFX leads 3, JNJ leads 8 of 11 comparable metrics.
Teleflex Incorporated
TFX · Healthcare
$125.12+0.75%Mixed
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | TFX | JNJ |
|---|---|---|
| Price | $125.12 | $261.79 |
| Market cap | $5.30B | $631B |
| Revenue (TTM) | $6.05B | $97.9B |
| Revenue growth | -10.6% | +5.6% |
| Net margin | -16.7% | 21.5% |
| Free cash flow | $229M | $22.2B |
| Net cash (debt) | ($2.61B) | ($27.8B) |
| 1-year price return | +0.3% | +37.0% |
| P/E | 28.7 | 29.9 |
| P/E vs own history (cheap-side %) | 64% | 16% |
| Dividend yield | 1.13% | 2.00% |
| Return on equity | -32% | 26% |
| Altman Z-score | 1.93 | — |
| CV checks passed | 8 of 11 | 10 of 11 |
| Employees | 15,500 | 140,800 |
Full résumé-style profiles: TFX CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.